Literature DB >> 28528983

Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathy.

Thanh H Nguyen1, Saifei Liu1, Gao J Ong1, Irene Stafford2, Michael P Frenneaux3, John D Horowitz4.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) and other forms of myocardial acute oxidative stress are associated with variable "shedding" of the endothelial glycocalyx (GCS) which can be quantitated ex vivo by release into plasma of glycocalyx components such as Syndecan-1 (SD-1). Previous studies have implicated release of both catecholamines and BNP as potential accentuating factors in GCS: since these are prominent aspects of the pathogenesis of Takotsubo cardiomyopathy (TTC), we hypothesised that TTC is associated with increased GCS and the extent of GCS is predictable on the basis of NT-proBNP and catecholamine releases.
METHODS: SD-1 concentrations were measured in 48 TTC patients acutely and after 3months, and compared with those in 12 healthy controls, and 17 patients with AMI. Correlations were sought between SD-1 levels markers of severity of TTC episodes in individual patients.
RESULTS: Acute SD-1 concentrations in TTC patients were elevated significantly (p<0.0001, 1-way ANOVA) compared to control values. There were no significant correlations between SD-1 concentrations and any markers of severity of acute TTC episodes, such as NT-proBNP or catecholamine release. Over 3months, SD-1 concentrations fell significantly (p=0.0002) to approximately the same values as in control subjects.
CONCLUSIONS: TTC is associated acutely with a marked increase in GCS. Potentially, GCS might contribute to increased coronary vascular permeability in TTC, thus dissociating development of myocardial oedema from severity of associated inflammation. Prevention of GCS represents a potential therapeutic option in TTC.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glycocalyx shedding; Myocardial inflammation; Syndecan-1; Takotsubo cardiomyopathy

Mesh:

Substances:

Year:  2017        PMID: 28528983     DOI: 10.1016/j.ijcard.2017.04.085

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

2.  Incidence and clinical/laboratory correlates of early hypotension in takotsubo syndrome.

Authors:  Gao Jing Ong; Olivia Girolamo; Jeanette Stansborough; Thanh Ha Nguyen; John David Horowitz
Journal:  ESC Heart Fail       Date:  2021-03-24

Review 3.  Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease).

Authors:  Ole Wilhelm Bøe; Kjell Sveen; Magne Børset; Kirk M Druey
Journal:  Am J Case Rep       Date:  2018-02-16

4.  Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome.

Authors:  Sven Y Surikow; Thanh H Nguyen; Irene Stafford; Matthew Chapman; Sujith Chacko; Kuljit Singh; Giovanni Licari; Betty Raman; Darren J Kelly; Yuan Zhang; Mark T Waddingham; Doan T Ngo; Alexander P Bate; Su Jen Chua; Michael P Frenneaux; John D Horowitz
Journal:  JACC Basic Transl Sci       Date:  2018-04-18

5.  Prognostic value of texture analysis from cardiac magnetic resonance imaging in patients with Takotsubo syndrome: a machine learning based proof-of-principle approach.

Authors:  Manoj Mannil; Ken Kato; Robert Manka; Jochen von Spiczak; Benjamin Peters; Victoria L Cammann; Christoph Kaiser; Stefan Osswald; Thanh Ha Nguyen; John D Horowitz; Hugo A Katus; Frank Ruschitzka; Jelena R Ghadri; Hatem Alkadhi; Christian Templin
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

Review 6.  Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis.

Authors:  Elias Rawish; Thomas Stiermaier; Francesco Santoro; Natale D Brunetti; Ingo Eitel
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241

7.  TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway.

Authors:  Jinxi Liu; Jie Xu; Jie Huang; Cunyang Gu; Qingjuan Liu; Wei Zhang; Fan Gao; Yuexin Tian; Xinyan Miao; Zixuan Zhu; Baiyun Jia; Yu Tian; Lunbi Wu; Hang Zhao; Xiaojuan Feng; Shuxia Liu
Journal:  Lab Invest       Date:  2021-04-14       Impact factor: 5.502

Review 8.  A systematic review of biomarkers in Takotsubo syndrome: A focus on better understanding the pathophysiology.

Authors:  Hilal Khan; David Gamble; Alice Mezincescu; Hassan Abbas; Amelia Rudd; Dana Dawson
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-19

9.  Impact of residual inflammation on myocardial recovery and cardiovascular outcome in Takotsubo patients.

Authors:  Lucie Lachmet-Thebaud; Benjamin Marchandot; Kensuke Matsushita; Chisato Sato; Charlotte Dagrenat; Stephane Greciano; Fabien De Poli; Pierre Leddet; Marilou Peillex; Sébastien Hess; Adrien Carmona; Charline Jimenez; Joe Heger; Antje Reydel; Patrick Ohlmann; Laurence Jesel; Olivier Morel
Journal:  ESC Heart Fail       Date:  2020-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.